About this item:

124 Views | 45 Downloads

Author Notes:

Matthew C. Freeman, mattew.freeman@emory.edu

We thank the Institut de Recherche en Santé de Surveillance Epidemiologique et de Formation (IRESSEF) in Dakar, Senegal for their partnership in this study. We gratefully acknowledge the participants who gave their time and insights to help us better understand Senegal’s vaccine delivery system, along with facilitators from the Ministry of Health and Social Action for supporting this research, especially Dr. Ousseynou Badiane and Dr. Abdoulaye Mangane. In addition, we thank Sarah Chesemore, Anna Rapp, Tove Ryan, and Ethan Wong from the Bill and Melinda Gates Foundation; Kate Buellesbach, Nancy Fullman, Nathaniel Gerthe, Gloria Ikilezi, Caitlyn Mason, David Phillips, and Oliver Rothschild, Jordan-Tate Thomas, and Angela Wang from Gates Ventures; and the Vaccine Exemplars Research Advisory Group for their insights, specifically Agnes Binagwaho, Laura Craw, Carolina Danovaro, Anuradha Gupta, Heidi Larson, Penelope Masumbu, Kate O’Brien, Helen Rees, Lora Shimp, and Aaron Wallace.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Subjects:

Research Funding:

This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA (OPP1195041) with a planning grant from Gates Ventures, LLC, Kirkland, WA.

Keywords:

  • Childhood vaccination
  • Health systems strengthening
  • Implementation research
  • Vaccine policy
  • Vaccine programming

Critical success factors for high routine immunization performance: A case study of Senegal

Show all authors Show less authors

Tools:

Journal Title:

Vaccine: X

Volume:

Volume 14

Publisher:

, Pages 100296-100296

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: The essential components of a vaccine delivery system are well-documented, but robust evidence is lacking on how policies and implementation strategies are operationalized to drive catalytic improvements in coverage. To address this gap, we identified success factors that supported improvements in routine immunization coverage in Senegal, especially from 2000 to 2019. Methods: We identified Senegal as an exemplar in the delivery of childhood vaccines through analysis of DTP1 and DTP3 coverage data. Through interviews and focus group discussions at the national, regional, district, health facility, and community-level, we investigated factors that contributed to high and sustained vaccination coverage. We conducted a thematic analysis through application of implementation science frameworks to determine critical success factors. We triangulated these findings with quantitative analyses using publicly available data. Results: The following success factors emerged: 1) Strong political will and prioritization of resources for immunization programming supported urgent allocation of funding and supplies; 2) Collaboration between the Ministry of Health and Social Action and external partners fostered innovation, capacity building, and efficiency; 3) Improved surveillance, monitoring, and evaluation allowed for timely and evidence-based decision making; 4) Community ownership of vaccine service delivery supported tailored programming and response to local needs; and 5) Community health workers spearheaded vaccine promotion and demand generation for vaccines. Conclusion: The vaccination program in Senegal was supported by evidence-based decision making at the national-level, alignment of priorities between governmental entities and external partners, and strong community engagement initiatives that fostered local ownership of vaccine delivery and uptake. High routine immunization coverage was likely driven by prioritization of immunization programming, improved surveillance systems, a mature and reliable community health worker program, and tailored strategies for addressing geographical, social, and cultural barriers.

Copyright information:

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote